Connect with us

Science

High Demand for Drug to Prevent Covid in the Vulnerable, Yet Doses Go Unused

Published

on

Sasha Mallett, Sue Taylor and Kimberly Cooley all have immune deficiencies that make them particularly susceptible to Covid-19, and all have tried to get the identical factor: a brand new therapy that may forestall the illness in individuals who both can’t produce antibodies after receiving a coronavirus vaccine or can’t get vaccinated in any respect.

Ms. Cooley, a liver transplant recipient in Duck Hill, Miss., obtained the antibody drug, known as Evusheld, from her transplant crew on the College of Mississippi Medical Heart with no hassle. However Ms. Taylor, of Cincinnati, was denied the therapy by two hospitals close to her house. And Dr. Mallett, a doctor in Portland, Ore., needed to drive 5 hours to a hospital prepared to present her a dose.

As a lot of the nation unmasks amid plummeting caseloads and contemporary hope that the pandemic is fading, the Biden administration has insisted it should proceed defending the greater than seven million Individuals with weakened immune methods who stay susceptible to Covid. Evusheld, which was developed by AstraZeneca with monetary assist from the federal authorities, is crucial to its technique.

However there may be a lot confusion in regards to the drug amongst well being care suppliers that roughly 80 p.c of the accessible doses are sitting unused in warehouses and on pharmacy and hospital cabinets — whilst sufferers like Ms. Taylor, 67, and Dr. Mallett, 38, go to nice lengths, usually with out success, to get them.

As a result of they’ve a weakened response to the coronavirus vaccine and should not be capable to battle off Covid-19, many immunocompromised folks have continued to isolate themselves at house and really feel left behind because the nation reopens. Evusheld, which is run in two consecutive injections, seems to supply long-lasting safety — maybe for half a 12 months — giving it appreciable enchantment for this group.

Advertisement

For now, although, the drug is in brief provide. As a result of it’s approved just for emergency use, it’s being distributed by the federal authorities. The Biden administration has bought 1.7 million doses — sufficient to completely deal with 850,000 folks — and had almost 650,000 doses prepared for distribution to the states as of this previous week, based on a senior federal well being official. However solely about 370,000 doses have been ordered by the states, and fewer than 1 / 4 of these have been used.

“There’s so many different people who find themselves scrapping and driving for hours to get Evusheld,” Ms. Cooley, 40, mentioned, “when in Mississippi it’s sitting on the cabinets.”

Interviews with medical doctors, sufferers and authorities officers counsel the explanations the drug goes unused are assorted. Some sufferers and medical doctors have no idea Evusheld exists. Some have no idea the place to get it. Authorities pointers on who ought to be prioritized for the drug are scant. In some hospitals and medical facilities, provides are being reserved for sufferers on the highest threat, reminiscent of latest transplant recipients and most cancers sufferers, whereas doses in different areas of the nation are being given out by means of a lottery or on a first-come, first-served foundation.

Hesitance can be a difficulty. Some medical doctors and different suppliers have no idea learn how to use Evusheld and are thus loath to prescribe it. The truth that it’s an antibody therapy will be complicated, as a result of most such remedies are used after somebody will get Covid quite than for preventive care.

Including to the confusion are revised Meals and Drug Administration pointers for Evusheld, launched final month, that known as for doubling the preliminary really useful dose after information confirmed the drug could also be much less efficient towards sure variants.

Advertisement

“It’s overwhelming and it’s all new,” mentioned Dr. Mitchell H. Grayson, chief of the allergy and immunology division at Nationwide Kids’s Hospital in Columbus, Ohio. “Suppliers are undoubtedly making an attempt to maintain up, it’s simply — I don’t understand how properly everybody’s doing with that.”

Roughly 3 p.c of Individuals are characterised by well being professionals as immunocompromised as a result of they’ve a illness that weakens their physique’s immune response or are receiving a therapy that does so. They embrace transplant recipients and folks with circumstances like most cancers, lupus and rheumatoid arthritis.

Evusheld’s arrival in December instantly set off a scramble. In Fb teams and on-line messages, sufferers and their family members started swapping details about learn how to get it. Authorities information units about Evusheld’s availability have been so advanced and complicated {that a} software program developer within the Seattle space, Rob Relyea, developed his personal mapping instrument that tracks how a lot of the drug is accessible and which suppliers have it.

“Individuals ought to know the place to go to get in line,” he mentioned.

Mr. Relyea, 51, had a vested curiosity: His spouse, Rebecca, is in remission from most cancers. They tried 10 hospitals unsuccessfully however then obtained the drug by means of luck, as Ms. Relyea’s identify was picked in a lottery for Evusheld at a hospital close to their house in early February, he mentioned.

Advertisement

However they haven’t heard something but about scheduling a second dose, which Ms. Relyea wants primarily based on the brand new suggestions.

Dr. Mallett, in Oregon, was one in all many who have been determined to get the drug. She has frequent variable immunodeficiency, a situation that retains her immune system from making sufficient antibodies. Her son began attending kindergarten in individual final fall, and when the Omicron variant surged, his instructor and classmates started testing constructive for Covid.

To seek out Evusheld, Dr. Mallett scoured a web based authorities database of shipments and spent weeks cold-calling hospitals, pharmacies and well being organizations that acquired the drug.

Advertisement

When she lastly discovered a hospital in La Grande, Ore., prepared to present her a dose, she labored together with her doctor to enroll as a affected person there. Then she dropped the whole lot and drove to the hospital within the rain, acquired the pictures and instantly turned again — an 11-hour journey in whole.

Dr. Mallett is extremely educated, medically savvy, rich and simply capable of take time away from her job — privileges that helped her get a dose, however that many others don’t have.

“I undoubtedly have lots of lingering moral qualms about how I went about getting this remedy,” she mentioned. “Did I make the most of our damaged system?”

Most of the well being staff Dr. Mallett known as whereas she was looking for a dose had not even heard of Evusheld — even when their workplaces had the drug in inventory.

Some consultants argue that Evusheld ought to go first to individuals who can’t get vaccinated due to extreme allergic reactions and to those that produce the fewest antibodies in response to coronavirus vaccines. However antibodies are just one part of the immune system, and the Facilities for Illness Management and Prevention nonetheless recommends towards utilizing exams that decide antibody ranges to evaluate somebody’s immunity.

Advertisement

“The most important drawback is that there’s completely no steering or prioritization or any rollout in place in any respect, and it’s been a large number,” mentioned Dr. Dorry Segev, a transplant surgeon at N.Y.U. Langone Well being who has been finding out coronavirus vaccines in transplant sufferers. “With out formal pointers, you actually can’t do something.”

The Biden administration is making an attempt to handle the confusion. Prime federal well being officers have been working to lift consciousness amongst state well being officers, suppliers and sufferers. They convened a name this previous week with advocates for the disabled to debate the revised dosing steering; in addition they urged affected person teams to companion with the administration on outreach and schooling efforts.

“I really feel actually strongly that this remedy has nice potential to assist the immune suppressed who don’t all the time reply to vaccinations,” mentioned Dr. Rachel Levine, the assistant secretary for well being within the Division of Well being and Human Companies, who spoke on the decision. However Dr. Levine mentioned she didn’t anticipate that the C.D.C.’s steering on antibody exams would change.

Sufferers who can’t be vaccinated are apparent candidates for Evusheld. However among the many vaccinated, Dr. Segev and different consultants say, the calculations turn into far murkier — and might contain assessments of different underlying circumstances or threat elements.

For sufferers who handle to get Evusheld, consultants say it’s nonetheless unclear precisely how a lot safety the remedy provides. It’s tough to gauge the affect of the drug in defending immunocompromised sufferers, as a result of many recruited for research have been avoiding dangerous behaviors and it will have been unethical to ask them to not. Researchers could not know the precise effectiveness of the drug for a lot of months.

Advertisement

Evusheld was discovered to supply safety akin to vaccines in a medical trial, however the variety of members who have been immunocompromised was by no means disclosed. Including to the uncertainty, AstraZeneca studied the drug earlier than Omicron surfaced. Analysis over the previous few months exhibits that Evusheld protects towards the variant, however it’s unclear to what diploma.

The shortage of strong data has annoyed Ms. Cooley, the liver transplant recipient in Mississippi. She continues to be taking the identical precautions as she did earlier than receiving Evusheld, reminiscent of getting groceries delivered, staying at house and seeing just a few trusted relations with masks on. That’s as a result of she cares for her aged mom and has seen numerous different aged folks, together with her grandmother, die from Covid-19 in her neighborhood, the place many individuals have chosen to not get vaccinated.

Some who can’t discover a dose of Evusheld have turned to on-line communities as an alternative of well being care organizations. They’re in search of assist from different immunocompromised folks, reminiscent of Dr. Vivian G. Cheung, 54, a doctor in Bethesda, Md., who has a genetic situation that impacts her immune system.

Dr. Cheung obtained a dose in January after calling numerous medical establishments for 2 weeks, and he or she has been serving to others navigate the method since then. She receives as much as 10 requests for assist daily, however she estimates that solely 1 / 4 of those that have reached out have succeeded in getting Evusheld.

Ms. Taylor, the girl in Cincinnati, has frequent variable immunodeficiency. However proper now, one hospital close to her is limiting its provide of Evusheld to its transplant sufferers, whereas one other just isn’t but accepting sufferers from outdoors its system. She is unable to look elsewhere; she mentioned she was uncomfortable driving lengthy distances due to her underlying well being circumstances.

Advertisement

Ms. Taylor mentioned that she didn’t wish to take a dose away from somebody who may want it extra, however that she would really feel much less “panic-stricken” if she might get Evusheld. She may be capable to begin seeing her youngsters indoors once more and inch again to the life she had earlier than Covid.

For now, she is in a holding sample of isolating, masking and hoping a dose will turn into accessible quickly.

Rebecca Robbins contributed reporting.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Science

If you're living with a drug or mental health problem, here's where to look for help

Published

on

If you're living with a drug or mental health problem, here's where to look for help

Fatal overdoses in the U.S. fell for the first time in five years in 2023, according to preliminary estimates recently released by the Centers for Disease Control and Prevention, but UCLA researcher Joseph Friedman warns that the new findings should not be interpreted to mean that the nation’s drug and mental health crises are abating.

Friedman has analyzed “deaths of despair” that result from overdose, suicide and liver disease due to alcoholism and found that while death rates for white Americans have dipped, rates have risen in recent years among people of color in the U.S., especially among Native and Black Americans. Illegal opioids such as fentanyl have ravaged Black and low-income communities in Los Angeles.

While it’s difficult to pinpoint the exact reasons behind substance abuse or suicide, Friedman as well as other experts in addiction medicine and mental health say racial inequality, economic distress and historical trauma have aggravated those problems in marginalized communities.

If you or someone you know needs immediate help for a mental health, substance-use or suicidal crisis, call or text 988, or chat online by visiting the suicide and crisis line’s website. For mental health resources and referrals, call the Los Angeles County Department of Mental Health’s Help Line 24/7 at (800) 854-7771.

Advertisement

Here are other organizations that offer information, counseling and support services:

Nakeya Fields, a licensed clinical social worker in Pasadena, founded the Black Mental Health Task Force, a coalition that brings together mental health professionals, clients, nonprofits, community organizations, educators and others in California to raise awareness about mental wellness. Her Therapeutic Play Foundation offers activities designed to improve resilience and coping skills through creative arts, play and sports. It provides individual, couples, group and family therapy for Black, Latinx, LGBTQ+ and other members of marginalized populations.

The American Indian Counseling Center, a division of the Los Angeles County Mental Health Department, offers crisis intervention, 24/7 intensive mental health services and counseling for all ages, as well as physician consultations for medications and referrals to culturally relevant support groups. Call (562) 402-0677 and ask to speak with the on-duty worker.

United American Indian Involvement’s behavioral health program provides outpatient substance use disorder treatment and mental health services to American Indians and Alaska Natives living throughout Los Angeles County. Visit the website or call (213) 202-3970.

Melanin and Mental Health offers an online network of Black and brown mental healthcare providers that is searchable by geographic area, issue type and treatment sought. It’s also possible to filter results by therapists’ racial background and specialty, as well as by insurance carrier.

Advertisement

The Black Mental Health Alliance offers confidential referrals to culturally competent mental health professionals who are in its database of licensed therapists.

Painted Brain advocates for mental wellness in underserved L.A. communities by offering self-care, relaxation and therapeutic art and play sessions, support groups and trainings for mental health professionals. As part of its peer-led model, many of the staff have experienced mental health issues themselves. Its community center and art space is located at 5980 W. Pico Blvd. in Los Angeles.

The Los Angeles LGBT Center offers individual, couples, family, group therapy and psychiatric care, as well as support for people struggling with substance use. The center has locations in West Hollywood, at Mi Centro in East L.A., at its Trans Wellness Center near MacArthur Park and in South L.A.’s Leimert Park neighborhood.

The Community Health Project Los Angeles provides services to people who use drugs by way of a harm-reduction approach that emphasizes offering clean needles as well as education on how to respond to an overdose.

Advertisement
Continue Reading

Science

Are 'deaths of despair' really more common for white Americans? A UCLA report says no

Published

on

Are 'deaths of despair' really more common for white Americans? A UCLA report says no

Nakeya Fields has seen how the stresses that come with being Black — racial injustice, financial strain, social isolation — can leave people feeling hopeless and push some into substance abuse.

It’s one of the reasons the Pasadena social worker started offering “therapeutic play” gatherings for Black mothers like herself and children.

“I’m trying to host more safe spaces for us to come and share that we’re suffering,” the 32-year-old said. “And honestly, the adults need play more than kids.”

Yet while Black and brown mental health practitioners such as Fields have labored to address these issues within their communities, a very different conversation has been occurring in the nation at large.

For years, discussions about America’s substance-abuse crisis have focused almost exclusively on the narrative that it is white, middle-age adults who face the greatest risk of dying from drug overdoses, alcoholic liver disease and suicide.

Advertisement

The theory, which was presented by two Princeton economists in 2015 and based on data from 1999 to 2013, argued that despair was behind rising premature mortality rates among white Americans, especially those who were less educated.

Virtually overnight, the “deaths of despair” concept began to drive the national discourse over populist far-right politics; the rise of Donald Trump; and deepening political polarization over such topics as addiction treatment, law enforcement and immigration.

But after roughly a decade, researchers at UCLA and elsewhere have begun to dismantle this idea.

In a study published recently in the journal JAMA Psychiatry, authors found that deaths of despair rates for middle-age Black and Native Americans have surged past those of white Americans as the overdose crisis moves from being driven by prescription opioids to illegal drugs such as fentanyl and heroin.

While the opioid crisis did raise drug overdose deaths among white Americans for a time, it was an anomaly, said Joseph Friedman, a social medicine expert at UCLA’s David Geffen School of Medicine who was the lead author of the journal analysis. In fact, by 2022 the rate for white Americans had started to dip.

Advertisement

“What’s really important is that now, with these three causes of death, the gap has closed, and it’s moving in the other direction,” Friedman said.

Sandra Mims, a community health worker with Community Health Project L.A., puts out boxes of Narcan — a naloxone nasal spray that reverses the effects of opioid overdose — at an event at MacArthur Park in Los Angeles on International Overdose Awareness Day.

(Mel Melcon / Los Angeles Times)

The analysis found that deaths of despair for Black Americans hit a rate of 103.81 per 100,000 people in 2022, compared with 102.63 for white Americans. The rate for Native American and Alaska Native populations was even higher at 241.7 per 100,000 people in 2022.

Advertisement

The UCLA analysis doesn’t specify the midlife personal issues that might have led to addiction or suicide.

But the authors say that flaws in the methodology of the 2015 deaths of despair report skewed its conclusions about who was most at risk. Specifically, Friedman said that it failed to give enough consideration to long-standing racial inequities that Black Americans experience in income, educational attainment, incarceration and access to quality medical care, all of which can contribute to drug use and poor mental health outcomes. And statistics for Native Americans weren’t factored in at all.

“It was burned into the American psyche that it was white people in the rural U.S.,” Friedman said. “It was just a very small piece of the truth that was very interesting but was widely sold as something it wasn’t.”

Another recent worrying sign, Friedman says: Deaths of despair among Latinos are starting to catch up to those among Black and Native Americans.

Princeton professors Anne Case and her husband Angus Deaton, winner of the 2015 Nobel Prize in economic sciences, were thrust into the media spotlight when their deaths of despair findings were first published. Deaton told NPR that during a visit to the White House, even President Obama asked him about the phenomenon.

Advertisement

Their 2020 book, “Deaths of Despair and the Future of Capitalism,” was described by publisher Princeton University Press as “a troubling portrait of the American dream in decline.”

“For the white working class, today’s America has become a land of broken families and few prospects. As the college educated become healthier and wealthier, adults without a degree are literally dying from pain and despair,” the publisher said.

Fields, who employs yoga and pottery in her therapy, said this framing was misleading and racially biased.

“I’m actually flabbergasted that somebody has a term called ‘deaths of despair,’” Fields said. “It’s ‘despair’ when white people experience this suffering. But when we experience it, it’s just what we have to deal with.”

Nakeya Fields

Nakeya Fields says it’s important to address mental wellness issues early, before people reach a crisis point and become another statistic.

(Jason Armond / Los Angeles Times)

Advertisement

Both Friedman and Fields say their critiques are not intended to minimize deaths among white Americans.

Still, Friedman wonders: “How do we empower Black and Native American communities in a way that enables them to treat these problems?”

Racism must be considered when trying to make sense of the crisis in premature deaths, says Dr. Helena Hansen, head of UCLA’s Department of Psychiatry and a senior author on Friedman’s analysis. Hansen, who is Black and specializes in addiction psychiatry, also co-authored the book “Whiteout: How Racial Capitalism Changed the Color of Opioids in America.”

For years, pharmaceutical companies steered expensive prescription pain medications, such as the opioid Oxycontin, as well as the most effective medications for opioid-use disorder, to white Americans with good access to healthcare, she said.

Advertisement

But at the same time, Black and brown Americans were unfairly subjected to law enforcement policies that prioritized incarceration for illegal drug use over increasing access to more humane medical strategies to help them, further harming already vulnerable communities, Hansen said.

“In our society, people with access to the new technologies and pharmaceuticals are more likely to be white,” Hansen says. “None of this is by accident. All of this is the direct result of careful racially and class-segmented marketing strategies by pharmaceutical companies.”

This two-tiered system arose because drug manufacturers, doctors and policymakers have for too long failed to see people from historically marginalized communities who live with addiction and mental health crises as worthy of the same sympathy and treatments that many white Americans receive, Hansen says.

Joseph Gone, a professor of anthropology at Harvard who has spent 25 years studying the intersection of colonialism, culture and mental health in Indigenous communities, agreed.

“Deaths of despair have been a reality for Indigenous communities since conquest and dispossession,” he said.

Advertisement

“It’s amazing how much grief our people contend with from early deaths — there are not that many communities in America that bear it quite the way we do,” said Gone, who is a member of the Aaniiih-Gros Ventre tribal nation of north-central Montana. “Until we acknowledge and take responsibility for the casualties of colonization, which endure to this day through deaths of despair, it’s going to be very hard to turn this around.”

Gone, who has collaborated with Friedman on previous research, says the mental health crisis in tribal nations is aggravated by widespread joblessness and generational poverty, and a lack of healthcare resources to treat people in need of immediate or long-term treatment.

Just one traveling psychiatrist serves reservations spread across both Montana and Wyoming — a region covering more than 243,300 square miles — mostly to manage patients’ prescriptions, he says.

And “for all of Indian country, we’re talking about a very small number of in-patient psychiatric facilities,” Gone says.

General practitioners can serve as a first line of defense, but they are not necessarily equipped to address the ongoing life crises that can lead to excessive drug and alcohol use, Gone says.

Advertisement

Fields says it’s important to address mental wellness issues early, before people reach a crisis point and become another statistic.

While her focus remains on Black women, she’s developed additional programming for adults, families and children, such as developmental screenings that measure for high stress levels. In June, Fields will co-present “Rap 4 Peace,” a conference and gala featuring hip-hop artists talking about mental health and reducing gun violence.

“This ‘tragedy of despair’ lives in us,” Fields says. “We breathe it. We go outside hoping that nobody will harm us or our children because they feel threatened by us. This is truly harmful to our bodies.”

Advertisement
Continue Reading

Science

SpaceX plans to launch 90 rockets from Vandenberg Space Force Base by 2026. Could that harm the coast?

Published

on

SpaceX plans to launch 90 rockets from Vandenberg Space Force Base by 2026. Could that harm the coast?

SpaceX plans to launch 90 rockets into space from a Santa Barbara County military base by 2026, tripling the number of blasts rocking the coastal community — and raising concerns from neighbors and environmental groups about the effects on marine life.

Founded by billionaire Elon Musk, SpaceX has ramped up the number of rocket launches from Vandenberg Space Force Base in recent years, and it has made clear its desire to increase the frequency of blastoffs. But during a California Coastal Commission hearing Friday, U.S. Space Force officials outlined for the first time its own plans to multiply the number of launches from the base, from 37 in 2023 to more than 120 a year by 2026.

The overwhelming majority of those rocket liftoffs would be conducted by SpaceX, which has already done more launches from the base than the commission has approved.

Last year SpaceX breached an agreement with the commission that limited the number of launches to six, sending 28 rockets into space.

Advertisement

It is seeking an agreement with the commission to do 36 launches a year, increasing to 90 in 2026.

The decision by the commission, which was created to protect the state’s coastal resources, will directly affect residents and marine life near the military base that hear and feel the rockets’ sonic booms.

It could also redirect the future of SpaceX, whose pursuit to redefine space exploration is already closely tied with U.S. military interests, given its work as a military contractor.

“The ultimate goal is for this to be more routine and not a huge deal,” said Space Force Col. Bryan Titus, operations vice commander at the base.

Formed in 2019, the U.S. Space Force has been looking to improve its ability to send rockets into space, Titus said, so SpaceX’s ability to launch with more frequency is a benefit to the U.S. military.

Advertisement

SpaceX launched 96 rockets in 2023 from Vandenberg and three other facilities: Cape Canaveral Space Force Station in Florida, NASA’s Kennedy Space Center in Merritt Island, Fla., and SpaceX Starbase in Boca Chica, Texas.

Environmental groups argue that turning launches into a routine event could affect marine life.

“We’re concerned that more frequent launches will result in permanent changes,” said Ana Citrin, legal and policy director for the Gaviota Coast Conservancy.

Federal agencies, including the U.S. Fish and Wildlife Service and National Marine Fisheries Service, monitor the effects of the liftoffs on such animals as sea otters, bats, western snowy plovers, California least terns and California red-legged frogs.

Thus far, the monitoring has shown that some of the animals might react to the blastoff by flushing, or fleeing from their nests and homes, but they return soon after, according to U.S. Space Force officials. No long-term effects have been seen, they said.

Advertisement

SpaceX did not respond to a request for comment.

Flushing or hunkering down after a blast are already signs of wildlife exhibiting signs of stress, said Duncan Leitch, a professor of integrative biology at UCLA.

Most animals can adapt to infrequent incidents, but exposure to more frequent stressful incidents can change their biology as well as their behavior, he said.

In the worst-case scenarios, he said, the ability of birds to communicate could be impeded, and migratory birds could avoid the area. Fish and other animals that use sound to communicate and navigate underwater — including whales — could be affected too.

“Over a longer period of time, there may be reductions in the population of fish as they move away from the sound, or they may be affected to the point that it affects their health,” Leitch said. “It would change the ecosystem as far as other animals that rely on the fish.

Advertisement

“Having sounds that are well into the damaging, or painful, range of decibels now occurring [100] times a year, the animals might not have the ability to change their behavior or accommodate these types of sounds.”

Some environmental groups, including the Surfrider Foundation, are asking the commission to reject the increase.

SpaceX “intends to begin increasing very rapidly, so we’re very concerned about this,” said Mandy Sackett, senior California policy coordinator for the Surfrider Foundation.

More frequent launches could change the way wildlife in the area responds in the long term, environmental groups said.

Members of the California Coastal Commission are also asking whether SpaceX should be entitled to circumvent the permit process, as federal agencies are.

Advertisement

Federal entities negotiate agreements with the commission but ultimately can move ahead even without commission approval. In such cases, the commission’s recourse would be through mediation or the courts.

Because SpaceX is a U.S. Space Force contractor, military officials argue that all launch operations at the base by the company are “federal activities.”

But U.S. Space Force officials said only 25% of the rockets launched into space by SpaceX are carrying payloads for the Department of the Defense.

The vast majority of the liftoffs are for the company’s private benefit, raising questions about why SpaceX can dispense with permits when 75% of its blasts from the base don’t involve the U.S. government.

“That is still pretty skewed for me,” Commissioner Mike Wilson said during a meeting Friday.

Advertisement

Some commissioners — whose focus is usually on environmental protection, development and water issues during their monthly meetings — also brought up the war in Ukraine during Friday’s discussion.

“I question the national security public benefit of concentrating that much power, literally communication power, in one company that we’re enabling in this case,” Wilson said. “[SpaceX] has already showed that it will play in international conflicts at the will of one human being.”

Wilson was referring to reports that Musk’s company refused to allow Ukraine to use satellite internet service from Starlink, a subsidiary of SpaceX, to help it carry out an attack against Russia in September 2022.

“If the idea is that we’re supporting these permits on the side that we’re promoting national defense, and then a single company is able to dismantle our allies during armed conflict — that really doesn’t align,” Commissioner Justin Cummings said.

“I suspect that would violate our strategies around national defense.”

Advertisement

Titus declined to address the question, saying it was “out of my lane,” but he said he would try to get answers to address the commissioners’ concerns.

Some commissioners on Friday also argued that SpaceX, not U.S. military officials, should be making the company’s case in front of the agency.

“When this comes back, I think it would be really important that a representative from SpaceX comes to the meeting,” Cummings said.

Cummings said it was “ridiculous” for SpaceX not to appear at the meeting, despite multiple efforts from the agency to have SpaceX officials speak.

“They obviously refuse to because they’ve never shown up,” he said.

Advertisement

On Friday, Commission Chair Caryl Hart suggested an agreement might not be possible unless SpaceX changes its stance.

“From my perspective,” Hart said, “I think we’re going to continue to hit significant obstacles in achieving a federal consistency ruling without having SpaceX.”

Continue Reading

Trending